Sativa Wellness Group #SWEL, the UK-based CBD business give London South East an operational update Watch Now

Less Ads, More Data, More Tools Register for FREE
Sativa Wellness Group #SWEL, the UK-based CBD business give London South East an operational update
Sativa Wellness Group #SWEL, the UK-based CBD business give London South East an operational updateView Video
Solo CEO re-engaging with prospective Tanzania gas stake buyers in the coming weeks #SOLO
Solo CEO re-engaging with prospective Tanzania gas stake buyers in the coming weeks #SOLOView Video

Latest Share Chat

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,056.00
Bid: 8,074.00
Ask: 8,078.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.05%)
Open: 8,127.00
High: 8,203.00
Low: 8,056.00
Yest. Close: 8,077.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
2nd Mar 20153:00 pmRNSTotal Voting Rights
17th Feb 20157:00 amRNSDirectorate Change
16th Feb 20157:00 amRNSPULMICORT RESPULES® US PATENT LITIGATION DECISION
5th Feb 20157:02 amRNSAZ to acquire Actavis' US respiratory portfolio
5th Feb 20157:00 amRNSFinal Results
4th Feb 20159:00 amRNSNotice of Results
2nd Feb 20152:00 pmRNSTotal Voting Rights
22nd Jan 20157:00 amRNSMAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA
14th Jan 20157:43 amRNSBRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT
2nd Jan 20152:00 pmRNSTotal Voting Rights
19th Dec 20145:40 pmRNSLYNPARZA APPROVED BY THE US FDA
18th Dec 20147:00 amRNSLYNPARZAT APPROVED IN THE EUROPEAN UNION
9th Dec 20147:00 amRNSMOVENTIG approved in the EU for OIC
5th Dec 20145:03 pmRNSJury verdict favours AZ in Nexium litigation
2nd Dec 20147:00 amRNSNew Drug Application for IRESSA accepted by US FDA
1st Dec 20142:00 pmRNSTotal Voting Rights
1st Dec 20142:00 pmRNSBlocklisting Interim Review
26th Nov 20147:00 amRNSPOSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY
24th Nov 20144:00 pmRNSPublication of Final Terms
24th Nov 20147:00 amRNSDUAKLIR GENUAIR APPROVED IN THE EU FOR COPD
19th Nov 20145:00 pmRNSLaunch and Pricing of a ?750m Bond
19th Nov 20149:41 amRNSStabilisation Notice
18th Nov 20147:00 amRNSAZ strategy on track to deliver growth and value
17th Nov 20144:00 pmRNSPublication of Supplementary Prospectus
12th Nov 20147:00 amRNSAMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS
10th Nov 20142:27 pmRNSDirector/PDMR Shareholding
6th Nov 20147:04 amRNSASTRAZENECA TO DIVEST MYALEPT TO AEGERION
6th Nov 20147:00 amRNS3rd Quarter Results
6th Nov 20147:00 amRNS3rd Quarter Results
5th Nov 20147:00 amRNSNotice of Results
4th Nov 20147:00 amRNSMEDIMMUNE ACQUIRES DEFINIENS
3rd Nov 20143:00 pmRNSTotal Voting Rights
3rd Nov 20147:00 amRNSAZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL
30th Oct 20147:00 amRNSUS FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS
24th Oct 201412:10 pmRNSOlaparib receives positive CHMP opinion
2nd Oct 20143:30 pmRNSDirector/PDMR Shareholding
1st Oct 20144:00 pmRNSTotal Voting Rights
29th Sep 20147:00 amRNSASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ESMO
26th Sep 201411:15 amRNSPositive CHMP Opinion for MOVENTIG (naloxegol)
16th Sep 20144:27 pmRNSFDA Approves MOVANTIK (naloxegol) Tablets
16th Sep 20147:00 amRNSAZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR
10th Sep 20144:30 pmRNSDirector/PDMR Shareholding
1st Sep 20144:00 pmRNSTotal Voting Rights
19th Aug 20147:00 amRNSUS DOJ Closes Investigation into Plato
19th Aug 20147:00 amRNSCAZ-AVI PHASE III RESULTS
14th Aug 20147:00 amRNSTRALOKINUMAB PHASE III START IN SEVERE ASTHMA
13th Aug 20147:00 amRNSPHASE III RESULTS LESINURAD COMBINATION THERAPY
4th Aug 20141:00 pmRNSDirector/PDMR Shareholding
1st Aug 20142:00 pmRNSTotal Voting Rights
1st Aug 201411:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.